| Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer G Di Lorenzo, G Tortora, FP D’Armiento, G De Rosa, S Staibano, ... Clinical cancer research 8 (11), 3438-3444, 2002 | 608 | 2002 |
| Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis G Di Lorenzo, R Autorino, G Bruni, G Carteni, E Ricevuto, M Tudini, ... Annals of oncology 20 (9), 1535-1542, 2009 | 238 | 2009 |
| Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial M de Sio, R Autorino, G Quarto, R Damiano, S Perdonà, G di Lorenzo, ... Urology 67 (1), 69-72, 2006 | 210 | 2006 |
| Gemcitabine versus bacille Calmette‐Guerin after initial bacille Calmette‐Guerin failure in non‐muscle‐invasive bladder cancer: a multicenter prospective randomized trial G Di Lorenzo, S Perdonà, R Damiano, A Faiella, F Cantiello, S Pignata, ... Cancer 116 (8), 1893-1900, 2010 | 193 | 2010 |
| Medical expulsive treatment of distal-ureteral stones using tamsulosin: a single-center experience MD Sio, R Autorino, GD Lorenzo, R Damiano, D Giordano, L Cosentino, ... Journal of endourology 20 (1), 12-16, 2006 | 179 | 2006 |
| Management of AIDS-related Kaposi's sarcoma G Di Lorenzo, PA Konstantinopoulos, L Pantanowitz, R Di Trolio, ... The lancet oncology 8 (2), 167-176, 2007 | 177 | 2007 |
| Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type multicenter study of 428 patients GF Stefanini, A Saggioro, V Alvisi, G Angelini, L Capurso, GD Lorenzo, ... Scandinavian journal of gastroenterology 30 (6), 535-541, 1995 | 177 | 1995 |
| Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study G Di Lorenzo, WD Figg, SD Fossa, V Mirone, R Autorino, N Longo, ... European urology 54 (5), 1089-1096, 2008 | 175 | 2008 |
| Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer G Di Lorenzo, G Cartenì, R Autorino, G Bruni, M Tudini, M Rizzo, M Aieta, ... Journal of Clinical Oncology 27 (27), 4469-4474, 2009 | 169 | 2009 |
| Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel JM Fitzpatrick, J Bellmunt, K Fizazi, A Heidenreich, CN Sternberg, ... European Journal of Cancer 50 (9), 1617-1627, 2014 | 162 | 2014 |
| Toxicities of targeted therapy and their management in kidney cancer G Di Lorenzo, C Porta, J Bellmunt, C Sternberg, Z Kirkali, M Staehler, ... European urology 59 (4), 526-540, 2011 | 150 | 2011 |
| Epigenetic control of gene expression: Potential implications for cancer treatment F Perri, F Longo, M Giuliano, F Sabbatino, G Favia, F Ionna, R Addeo, ... Critical reviews in oncology/hematology 111, 166-172, 2017 | 146 | 2017 |
| Castration-resistant prostate cancer: current and emerging treatment strategies G Di Lorenzo, C Buonerba, R Autorino, S De Placido, CN Sternberg Drugs 70, 983-1000, 2010 | 144 | 2010 |
| How to decrease pain during transrectal ultrasound guided prostate biopsy: a look at the literature R Autorino, M De Sio, G Di Lorenzo, R Damiano, S PerdonÀ, L Cindolo, ... The Journal of urology 174 (6), 2091-2097, 2005 | 138 | 2005 |
| Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis R Damiano, G Di Lorenzo, F Cantiello, M De Sio, S Perdonà, ... European urology 52 (3), 648-657, 2007 | 134 | 2007 |
| Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2–10 ng/ml M Ferro, D Bruzzese, S Perdona, A Marino, C Mazzarella, G Perruolo, ... PloS one 8 (7), e67687, 2013 | 131 | 2013 |
| Immunotherapy for the treatment of prostate cancer G Di Lorenzo, C Buonerba, PW Kantoff Nature reviews Clinical oncology 8 (9), 551-561, 2011 | 127 | 2011 |
| Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis S Bracarda, R Iacovelli, L Boni, M Rizzo, L Derosa, M Rossi, L Galli, ... Annals of Oncology 26 (10), 2107-2113, 2015 | 124 | 2015 |
| Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial S Perdonà, R Autorino, S De Placido, M D'Armiento, A Gallo, R Damiano, ... The lancet oncology 6 (5), 295-300, 2005 | 123 | 2005 |
| Bladder‐sparing, combined‐modality approach for muscle‐invasive bladder cancer: a multi‐institutional, long‐term experience S Perdonà, R Autorino, R Damiano, M De Sio, B Morrica, L Gallo, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 118 | 2008 |
